PGNY

Progyny, Inc.
  • Healthcare
  • Medical - Healthcare Plans
  • $2.14B market cap
Forecast run · Sep 14, 2026Upside rank 1831 of 3,136

Model Signal

ForecastQ Daily Probabilities
29.3%
49.4%
15.7%

Analyst Consensus

Recommendation2.30/5 Buy
Last price$27.35
Price target$35.50
Implied move+29.8%
Analysts20

ForecastQ Portfolios

PGNY is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

ForecastQ

Quantitative stocks signals powered by AI


The information provided is for educational purposes only and should not be considered financial advice. Past performance is not indicative of future results. ForecastQ is a research platform, a living documentation of an engineering experiment. We are not financial advisors.


© ForecastQ. All rights reserved.